Clinical Trials · NCT07781150
Mazdutide Plus LNG-IUS for Fertility-Sparing Treatment of AEH or Early Endometrial Cancer
- Phase
- Phase 2
- Recruitment status
- Not Yet Recruiting
- Sponsor
- Tongji Hospital
- Enrollment
- 128
- Start date
- Nov 2026
- Locations
- 6 sites, China
- Primary endpoint
- Complete response rate of endometrial lesions at 24 week